Quick Answer
Magnesium Insomnia Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Background & aim Diabetic nephropathy is a common complication in patients with type 2 diabetes, and insomnia may exacerbate renal dysfunction.
Key Takeaways
- 01Background & aim Diabetic nephropathy is a common complication in patients with type 2 diabetes, and insomnia may exacerbate renal dysfunction. [Khalid S (2026)]
- 02This study aimed to evaluate the effects of magnesium and potassium supplementation on diabetic nephropathy markers in diabetic patients with insomnia. [Khalid S (2026)]
- 03Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. [Conti F (2026)]
- 04While both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes. [Conti F (2026)]
The current Migaku evidence database contains 2 reusable source documents for Magnesium Insomnia Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Background & aim Diabetic nephropathy is a common complication in patients with type 2 diabetes, and insomnia may exacerbate renal dysfunction. [Khalid S (2026); evidence level 2]
- This study aimed to evaluate the effects of magnesium and potassium supplementation on diabetic nephropathy markers in diabetic patients with insomnia. [Khalid S (2026); evidence level 2]
- Failure to meet the recommended 7-9 hours of restful sleep per night is known to increase the risk of several health conditions, reason why regular and adequate sleep should be seen as a priority instead of an unnecessary commodity easily traded as required by the commitments of our busy lives. [Conti F (2026); evidence level 4]
- While both the quantity and the quality of sleep can be largely improved with relatively straightforward practices dictated by good sleep hygiene, emerging research suggests that dietary and supplementation protocols focused on certain foods, nutrients, and biochemical compounds with sleep-promoting properties can act as subsidiary sleep aids in complementing these behavioral changes. [Conti F (2026); evidence level 4]
- The scope of this narrative review is to summarize the available evidence on the potential benefits of selected nutraceuticals in the context of circadian rhythm and sleep disturbances, namely melatonin, magnesium, omega-3 fatty acids, tart cherry juice, kiwifruit, apigenin, valerian root, L-theanine, glycine, ashwagandha, myoinositol, Rhodiola rosea, and phosphatidylserine. [Conti F (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources